Clinical Trial

AMT-676 in Patients With Advanced Solid Tumors

Name: AMT-676 in Patients With Advanced Solid Tumors — clinical trial record (NCT06400485)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a first-in-human, open-label, multicenter Phase Ia/Ib study of AMT- 676, followed by an open-label, multicenter, dose-escalation.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2024-05-01; most recent amendment 2026-05-14.

Status change: Not Yet Recruiting → Recruiting 2024-09-24

Trial Details

NCT Number	NCT06400485
Lead Sponsor	Multitude Therapeutics Inc.
Conditions	Advanced Solid Tumors
Enrollment	24 participants
Start Date	2024-06-18
Primary Completion	2027-05-15 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-18